Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Type 1 Diabetes
NCT01722240Phase 3Completed
- Sponsor
- University at Buffalo
- Start
- Nov 2012
- Primary completion
- Jan 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by University at Buffalo. Started Nov 2012; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01722240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01722240.